Edinburgh Research Explorer

An evaluation of respiratory administration of measles vaccine for prevention of acute lower respiratory infections in children

Research output: Contribution to journalArticle

Related Edinburgh Organisations

Open Access permissions

Open

Documents

  • Download as Adobe PDF

    Rights statement: © 2011 Higginson et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

    Final published version, 343 KB, PDF document

    Licence: Creative Commons: Attribution (CC-BY)

http://www.biomedcentral.com/1471-2458/11/S3/S31
Original languageEnglish
Pages (from-to)S31
JournalBMC Public Health
Volume11 Suppl 3
DOIs
Publication statusPublished - 2011

Abstract

Measles was responsible for an estimated 100,000 deaths worldwide in 2008. Despite being a vaccine-preventable disease, measles remains a major cause of morbidity and mortality in young children. Although a safe and effective injectable measles vaccine has been available for over 50 years it has not been possible to achieve the uniformly high levels of coverage (required to achieve measles eradication) in most parts of the developing world. Aerosolised measles vaccines are now under development with the hope of challenging the delivery factors currently limiting the coverage of the existing vaccine.

Download statistics

No data available

ID: 3460476